Observational Study of Pain Reduction in Late-Stage Cancer Patients Who Are Receiving Low-Dose Chemotherapy

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02443675

Enrollment

300

Registered

2015-05-14

Start date

2015-05-31

Completion date

2020-12-31

Last updated

2015-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Pain

Brief summary

Observational Study of Pain Reduction in Late Stage Cancer Patients Receiving Low-Dose Chemotherapy

Detailed description

Observational Study of Pain Reduction in Late Stage Cancer Patients who are Receiving Low-Dose Chemotherapy (Metabolic Targeting)

Interventions

None listed

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Patient requests to be included in this study

Exclusion criteria

* Patient does not request to be included in this study

Design outcomes

Primary

Measure	Time frame	Description
Pain Level Self Assessment	5 years	From enrollment in study to termination of study (August 2020)

Outcome results